🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a Multiple-dose, steady state, three-way reference-replicated cross...
Status
Completed
Location
Woodland International Research Group, Inc.
Start Date
2013-07
Trial ID
NCT01948024
Bipolar disorder is characterized by mood swings that range from from high ...
Status
Completed
Location
Multiple Locations
Start Date
2005-07
Trial ID
NCT00159783
Treatments Being Tested
This study is designed to describe asenapine prescribing patterns in the Un...
Status
Completed
Location
Multiple Locations
Start Date
2013-04-01
Trial ID
NCT01498770
This study will test the effectiveness of two different treatments for chil...
Status
Completed
Location
University of Maryland
Start Date
2009-01
Trial ID
NCT00806234
This is a 12-week study that will test the safety and efficacy of asenapine...
Status
Completed
Location
Multiple Locations
Start Date
2005-06-02
Trial ID
NCT00145470
Schizophrenia is a brain disease. The primary features of schizophrenia are...
Status
Completed
Location
Multiple Locations
Start Date
2005-04
Trial ID
NCT00156091
Treatments Being Tested
Schizophrenia is a brain disease. The primary features of schizophrenia are...
Status
Completed
Location
Multiple Locations
Start Date
2005-09
Trial ID
NCT00156065
Treatments Being Tested
The purpose of this 9-day study is to determine if: 1. Pantoprazole modifi...
Status
Withdrawn
Location
UBC Hospital - Detwiller Pavilion
Start Date
2014-09
Trial ID
NCT02213887
Treatments Being Tested
This study is designed to evaluate whether asenapine, which is approved by ...
Status
Completed
Location
Multiple Locations
Start Date
2010-09-28
Trial ID
NCT01190267
Treatments Being Tested
The primary features of schizophrenia and schizoaffective disorder are posi...
Status
Completed
Location
Multiple Locations
Start Date
2004-09
Trial ID
NCT00212771
Treatments Being Tested